DEBT | NOTE 2. DEBT Senior Convertible Notes The Company entered into a Securities Purchase Agreement (“2013 SPA”) dated June 18, 2013 with Cobrador Multi-Strategy Partners, LP (“Investor” or “Cobrador”) pursuant to Cobrador providing an aggregate of $400,000 financing through senior convertible notes and warrants. During the nine months ended September 30, 2016, the terms of the convertible notes were extended until December 31, 2017. Pursuant to the extension the maturity of the convertibles notes are for more than one year as of September 30, 2016 and accordingly are reclassified as noncurrent liabilities. In connection with the extension, the Company extended the expiration dates of Series A Warrants by one year. The fair value of the Series A Warrants did not materially change due to the extension. During the nine months ended September 30, 2016, the Company issued 1,250,000 shares of common stock upon Cobrador converting three Senior Convertible Notes in the face amount of $62,500. As of September 30, 2016, the Senior Convertible had an aggregate face and carrying value of $310,000 ($372,500 at December 31, 2015). On June 30, 2016, the Company entered into an agreement with Cobrador and issued an additional Senior Convertible Note in the face amount of $108,804 in settlement of accrued interest, additional interest, fees and penalties. The additional interest, fees and penalties $72,734 and this amount was charged to operations as debt discount amortization during the nine months ended September 30, 2016. The Senior Convertible Note is due on December 31, 2017 and can be convertible into shares of common stock at a conversion price $.05 per share. The Company determined that the Senior Convertible Note had beneficial conversion feature and allocated $87,043 as debt discount representing the beneficial conversion. The Company will amortize the debt the discount over the term of the note. During the three and nine months ended September 30, 2016, the Company amortized debt discount of $14,507 related to the Senior Convertible Note issued in June 2016. As of September 30, 2016, the Senior Convertible Note issued in June 2016, had a carrying value of $36,268 net of discount of $72,536. Pursuant to 2013 SPA, there were an aggregate of 11.2 million Series A Warrants expiring at various dates between June 2017 and December 2018 and an aggregate of 12 million Series B Warrants expiring at various dates between June 2018 and November 2019. Promissory Notes Payable During the nine months ended September 30, 2016, the Company issued nine unsecured promissory notes and borrowed an aggregate amount of $474,000. The promissory notes bear interest at 10% per annum, with a provision for an increase in the interest rate upon an event of default as defined therein, and were due at various due dates in June 2016. On June 30, 2016 the Company issued new convertible promissory notes and repaid the promissory notes as further detailed in the Convertible Note Payable section. In addition, during the nine months ended September 30, 2016, the Company borrowed an aggregate of $58,800 pursuant to five unsecured promissory notes. The notes bear interest at 19% and the borrowings are payable together with interest over a period of six months from the date of borrowing. The Company repaid an aggregate of $45,833 of borrowings during the nine months ended September 30, 2016 and the balance outstanding on these notes at September 30, 2016 was $24,050 ($11,083 at December 31, 2015). The Company also borrowed $30,000 pursuant to a demand promissory note that bears interest at 10% during the nine months ended September 30, 2016. In January and October 2015, the Company entered into two separate 24 month equipment financing agreements with Perkin Industries, LLC (“the Lender”) for equipment in the aggregate amount of $137,750 with an annual interest rate of 15%. The Lender received an aggregate of 110,200 warrants with an exercise price of $0.35 per share and a term of three years in connection with this financing which was recorded as a debt discount and derivative warrant liability due to the “down round provision” in the amount of $1,237. During the three and nine months ended September 30, 2016, the Company amortized debt discount of $146 and $439, respectively, and the carrying value of this financing is $137,750 at September 30, 2016. The fair value of the warrant liability related to Perkin equipment financing obligations was $1,711 as of September 30, 2016 ($2,920 December 31, 2015). Convertible Note Payable During the nine months ended September 30, 2016, the Company repaid one convertible note payable in Canadian dollars that was acquired in connection with the U-Vend Canada merger on January 7, 2014 in the face amount of $19,250. The Company has another convertible 18% note in the principal carrying value of $76,237 as of September 30, 2016. During the three and nine months ended September 30, 2016, the Company recorded an unrealized (loss)/ gain on foreign currency translation related to these notes and the related accrued interest of $1,776 and $(7,251), respectively. The Company recorded an unrealized gain on foreign currency translation of $8,602 and an unrealized gain on foreign currency translation of $24,561 during the three and nine months ended September 30, 2015, respectively, related to these notes and the accrued interest. During the year ended December 31, 2015, the Company issued eleven 9.5% subordinated convertible notes aggregating $441,000 pursuant to 2015 Stock Purchase Agreement (2015 SPA). In connection with these borrowings, the Company granted a total of 735,002 warrants with an exercise price of $0.40 per share and 5 year terms. The Company allocated $8,113 of proceeds received to debt discount based on the computed fair value of the convertible notes and warrants issued. During the three and nine months ended September 30, 2016 the Company recorded $129 and $2,309, respective, as amortization of debt discount on the 2015 SPA subordinated convertible notes. As of September 30, 2016, outstanding 2015 SPA notes had a face value of $441,000 ($441,000 at December 31, 2015). The debt discount of $2,309 at December 31, 2015 is fully amortized, resulting in a carrying value of $441,000 ($438,691 at December 31, 2015). On June 30, 2016, the Company issued five Convertible Notes in the aggregate face amount of $761,597 pursuant to 2016 Stock Purchase Agreement (2016 SPA). 2016 SPA Notes are due in 24 months and bear interest at 9.5% and are convertible into shares of common stock at a conversion price of $0.17 per share. The Company satisfied its obligations for: previously issued Promissory Notes of $549,000, accrued interest of $38,615, lease principal installments of $47,466, previously accrued registration rights penalties of $22,156, due to an ex-officer of $81,250, and additional interest, expenses, fine and penalties of $23,110 through the issuance of 2016 SPA Notes. The Company charged additional interest, expenses, fine and penalties $23,110 to operations as amortization of debt discount and deferred financing costs during the nine months ended September 30, 2016. In connection with these borrowings, the Company granted a total of 2,239,990 warrants with an exercise price of $0.30 per share with a five year expiration. The Company allocated $19,242 to debt discount based on the computed fair value of the convertible notes and warrants issued, and the debt discount is classified as derivative warrant liability due to the “down round provision” in the warrants. During the three and nine months ended September 30, 2016, the Company amortized $2,405 of debt discount related to 2016 SPA. As of September 30, 2016, outstanding 2016 SPA had a face value of $761,957 and debt discount of $16,837 resulting in carrying value of $744,760. During the three months ended September 30, 2016, the Company issued four Convertible Notes (Cobrador 2016 Convertible Notes) in the face amount of $115,000. The notes are due in due 24 months and bear interest at 9.5% and are convertible into shares of common stock at a conversion price of $0.17 per share. In connection with these borrowings, the Company granted a total of 338,235 warrants with an exercise price of $0.30 per share with a five year expiration. The Company allocated $1,994 to debt discount based on the computed fair value of the convertible notes and warrants issued, and the debt discount is classified as derivative warrant liability due to the “down round provision” in the warrants. During the three and nine months ended September 30, 2016, the Company amortized $249 of debt discount resulting in un amortized debt discount of $1,745 and carrying vale of $113,255 at September 30, 2016. As of September 30, 2016, five convertible notes payable with a face amount of $237,000 ($175,313 at December 31, 2015) are currently due for repayment. The terms of the notes, amongst other things, provide for payment of additional interest if repayments are not made on due dates. The Company is in discussion with the note holders for an extension of the repayment date, however, as of November 4, 2016 no agreement has been reached. Additional interest payable, if any, on the notes as of September 30, 2016 was immaterial. Other Assets - Deferred Financing Costs Financing costs associated with the Senior Convertible Notes, certain of the Subordinated Convertible Notes payable and planned financing are included in deferred financing costs on the condensed consolidated balance sheets at September 30, 2016 and December 31, 2015. These costs are amortized over the term of the respective notes. The Company incurred approximately $107,000 of financing costs during the nine months ended September 30, 2016, including $7,000 related to maturity extensions of a convertible note paid in shares of the Company’s common stock and $100,000 for a proposed financing. Amortization of financing costs for the three and nine months ended September 30, 2016 was $1,017 ($32,315 in 2015) and $27,010 ($80,436 in 2015), respectively. In addition, during the three months ended September 30, 2016 the Company charged to operations as amortization of deferred financing costs $150,000 incurred for a proposed financing as the Company determined that it is unlikely that the proposed financing will be completed. |